In conclusion, CHCHD2 is upregulated via YAP/TAZ-TEAD in NASH livers and consequently promotes liver fibrosis by activating the Notch pathway and enhancing osteopontin production. The gene discussed is CHCHD2; the disease is metabolic dysfunction-associated steatohepatitis.